CMS issued its final rule updating Medicare payment rates for inpatient psychiatric facilities for fiscal year 2027 on July 29, and the topline number is unremarkable: a net 2.2 percent increase to the federal per diem base rate, from $892.87 to $912.40 for facilities meeting quality reporting requirements, roughly in line with prior years and with what other Medicare prospective payment categories are seeing this cycle. That number is the one likely to travel. It is not the part of this rule that deserves the closest read.
What the rate update actually contains
The base rate increase applies to freestanding psychiatric hospitals and distinct-part psychiatric units within acute care hospitals, the facilities Medicare pays under the Inpatient Psychiatric Facility Prospective Payment System. Facilities that fail to submit quality data under the IPF Quality Reporting Program receive a smaller increase, landing at $894.56, a real, if modest, financial incentive structure built into the update itself. Electroconvulsive therapy, billed as a separate per-treatment payment under the same system, rises by the same 2.2 percent, to $688.59 for compliant facilities. CMS also trimmed the labor-related share of the payment formula slightly, from 79 percent to 78.9 percent, and is retiring two measures from the quality reporting program while adding a new standardized patient assessment instrument that facilities must begin using in October 2027, for the FY 2029 payment cycle. None of this is dramatic on its own. It is the standard machinery of an annual reimbursement update.
The part that isn’t routine
Inside the same rule, CMS finalized a new policy that has nothing to do with the annual rate cycle: starting in FY 2028, outlier payments at the facility level will be capped at no more than 20 percent of an IPF’s total Medicare PPS payments in a given year, applying to facilities with at least 50 stays annually. Outlier payments exist to protect Medicare from underpaying for unusually expensive patient stays. CMS’s own stated rationale for the cap is specific: the agency’s analysis found that certain facilities report exceptionally high costs, driven primarily by fixed routine expenses, labor, real estate, overhead, that do not vary meaningfully from one patient to the next, yet these facilities are drawing outlier payments on a disproportionate share of their claims. A cap aimed at that pattern is a structural correction targeting a specific subset of high-cost providers, not a broad-based rate adjustment affecting the whole sector evenly.
Why the distinction matters for who actually reads this rule closely
A 2.2 percent base-rate increase affects every IPF roughly proportionally. An outlier-payment cap does the opposite: it is specifically designed to affect the facilities furthest from the norm, the ones whose cost structure has been generating outlier payments most heavily. For a publicly traded operator like Acadia Healthcare or Universal Health Services, both of which derive a material share of revenue from Medicare inpatient psychiatric admissions, the practical impact of this rule depends far more on where their specific facilities sit relative to that outlier threshold than on the 2.2 percent headline figure that will show up in most coverage. A facility mix skewed toward higher-acuity, higher-cost stays, precisely the kind of case mix an outlier policy is built to constrain, would feel this rule differently than the base-rate number alone suggests, in either direction depending on how close individual facilities already run to the new 20 percent ceiling.
Why the effective date is worth noting on its own
The cap does not take effect until FY 2028, a full year after this rate update. That gives affected operators real lead time to review their own outlier-payment history and facility-level cost structure before the policy actually bites, which is a meaningfully different situation than a cap taking effect immediately would create. It also means the near-term financial story here is genuinely just the 2.2 percent increase; the structural story is a known, dated future event that sophisticated operators and investors have a full year to model and prepare for, not a surprise landing today.
The caveats
This piece does not have visibility into either Acadia’s or UHS’s specific facility-level outlier payment history, and nothing here should be read as a prediction about how the cap will affect either company specifically; that requires the kind of facility-by-facility cost data only the companies themselves, or CMS’s own claims data, can actually provide. The rate update and the outlier cap are both final as written, but CMS rules of this kind occasionally see technical corrections or delayed enforcement in the following months, and the FY 2028 timeline in particular leaves room for further rulemaking before the cap actually applies.
The frame
Every year, CMS’s inpatient psychiatric facility rate update gets read the same way: is the base rate increase enough to keep pace with the sector’s actual cost growth. That is a legitimate question and worth asking again this year. But a rule that also caps outlier payments specifically for high-fixed-cost facilities, effective on a one-year delay, is doing something the base-rate headline does not capture at all, targeting a structural cost pattern CMS has apparently decided has gone far enough to warrant its own correction. For operators and investors in inpatient behavioral health, the 2.2 percent number is the easy part of this rule to model. The outlier cap, and where each facility actually sits relative to that new ceiling, is the part that will separate which operators find FY 2028 to be a non-event and which find it a real constraint on how they’ve been running their highest-cost units.